Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Al-Hakim

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Expert Review of Clinical Immunology|December 20, 2022
An update on VEXAS syndromeAdam Al-Hakim, Sinisa Savic
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|December 16, 2024
Sequelae of B-Cell Depleting Therapy: An Immunologist's PerspectiveMark Kacar, Adam Al-Hakim, Sinisa Savic
Journal of Clinical Medicine|March 28, 2024
The Scope and Impact of Viral Infections in Common Variable Immunodeficiency (CVID) and CVID-like Disorders: A Literature ReviewAdam Al-Hakim, Mark Kacar, Sinisa Savic
Journal of Inflammation Research|October 14, 2022
Improving Diagnosis and Clinical Management of Acquired Systemic Autoinflammatory DiseasesAdam Al-Hakim, Anoop Mistry, Sinisa Savic
The Lancet. Rheumatology|September 7, 2025
VEXAS syndrome and immune-mediated rheumatic diseases: overlaps in clinical features and mechanismsArvind Kaul, Adam Al-Hakim, Helen Lachmann, et al.
Rheumatology (Oxford, England)|June 26, 2025
Clinical Features in VEXAS syndrome: a systematic reviewAdam Al-Hakim, Scott Goldberg, Ségolène Gaillard, et al.
British Journal of Haematology|May 26, 2025
Mapping VEXAS-associated and rare UBA1 variants in the United Kingdom: Insights from patient cohorts and the general populationAna Martinez Rodriguez, Leon Chang, Dorota Rowczenio, et al.
The Lancet. Rheumatology|May 24, 2025
Treatment outcomes in patients with VEXAS syndrome: a retrospective cohort studyAdam Al-Hakim, Roochi Trikha, Ei Ei Phyu Htut, et al.
Frontiers in Immunology|October 10, 2022
Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experienceAdrian M Shields, Susan Tadros, Adam Al-Hakim, et al.
Arthritis Care & Research|July 13, 2026
Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS-DAI)Kevin Byram, Heřman Mann, Danielle Hammond, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Expert Review of Clinical Immunology|December 20, 2022
An update on VEXAS syndromeAdam Al-Hakim, Sinisa Savic
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|December 16, 2024
Sequelae of B-Cell Depleting Therapy: An Immunologist's PerspectiveMark Kacar, Adam Al-Hakim, Sinisa Savic
Journal of Clinical Medicine|March 28, 2024
The Scope and Impact of Viral Infections in Common Variable Immunodeficiency (CVID) and CVID-like Disorders: A Literature ReviewAdam Al-Hakim, Mark Kacar, Sinisa Savic
Journal of Inflammation Research|October 14, 2022
Improving Diagnosis and Clinical Management of Acquired Systemic Autoinflammatory DiseasesAdam Al-Hakim, Anoop Mistry, Sinisa Savic
The Lancet. Rheumatology|September 7, 2025
VEXAS syndrome and immune-mediated rheumatic diseases: overlaps in clinical features and mechanismsArvind Kaul, Adam Al-Hakim, Helen Lachmann, et al.
Rheumatology (Oxford, England)|June 26, 2025
Clinical Features in VEXAS syndrome: a systematic reviewAdam Al-Hakim, Scott Goldberg, Ségolène Gaillard, et al.
British Journal of Haematology|May 26, 2025
Mapping VEXAS-associated and rare UBA1 variants in the United Kingdom: Insights from patient cohorts and the general populationAna Martinez Rodriguez, Leon Chang, Dorota Rowczenio, et al.
The Lancet. Rheumatology|May 24, 2025
Treatment outcomes in patients with VEXAS syndrome: a retrospective cohort studyAdam Al-Hakim, Roochi Trikha, Ei Ei Phyu Htut, et al.
Frontiers in Immunology|October 10, 2022
Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experienceAdrian M Shields, Susan Tadros, Adam Al-Hakim, et al.
Arthritis Care & Research|July 13, 2026
Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS-DAI)Kevin Byram, Heřman Mann, Danielle Hammond, et al.
Pageof 1